Anemia detected in health care is associated with an increased risk of both cancer and higher mortality, according to a new ...

Research published in BMJ Journals links newly developed anemia to significantly higher chances of cancer diagnosis and ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved sutimlimab-jome infusion for the treatment of adults with a rare type of anemia.

Myelodysplastic syndromes (MDS) are blood cancers caused by an insufficient production of healthy blood cells. Production of irregular cells leads to anemia, where the body’s organs and tissues don’t ...

Aplastic anemia is when your bone marrow can’t make enough healthy blood cells, including red blood cells, white blood cells, and platelets. A CBC measures blood cell levels and is used to diagnose ...

Anemia is a major health problem, with nearly 2 billion people affected globally. It afflicts more people worldwide than low back pain or diabetes – or even anxiety and depression combined. Despite ...

Cirrhosis is a risk factor for anemia, and anemia can indicate worse cirrhosis outcomes. Cirrhosis may cause anemia, leading to red blood cell destruction, folate deficiency, or internal bleeding.

Fanconi anemia is an aggressive, life-threatening disorder. Most individuals living with this rare genetic condition, characterized by bone marrow failure and cancer predisposition, survive into ...

Ferumoxytol, a novel intravenous form of iron that permits rapid administration of large doses, has been shown to be effective for treating iron deficiency in chronic kidney disease (CKD) patients on ...

If you have Crohn’s disease, you might feel tired or lethargic most of the time. While these are symptoms of Crohn’s, they might mean you also have anemia. It’s a common problem, with just under half ...

A Mother's Day blood drive was held Sunday in National City in honor of a baby with a rare form of anemia. Sevey Quinto, a 7-month-old baby, requires regular blood transfusions to stay alive. “We’re ...